The United Arab Emirates has enacted a voluntary product recall for specific batches of Nestlé infant nutrition formulas as a precautionary health measure. This action, coordinated between the Emirates Drug Establishment (EDE) and the global food manufacturer, follows the discovery of a potential microbial contaminant in a raw material used during production.
The affected products include several lines of specialized infant formula: NAN Comfort 1, NAN Optipro 1, NAN Supreme Pro 1, 2 and 3, Isomil Ultima 1, 2 and 3, and the Alfamino range. The EDE emphasized that this recall is proactive and preventative, initiated after quality controls detected traces of Bacillus cereus bacteria, which can produce the toxin cereulide.
This UAE recall forms part of a broader international response, with at least 37 countries across Europe, Africa, the Americas, and Asia having issued similar health advisories regarding these specific batches. National food safety authorities in Brazil, China, South Africa, Mexico, and Australia have all implemented comparable precautionary measures.
Critical to public reassurance, the EDE confirmed that no illnesses or adverse health events related to these products have been reported within the UAE to date. All other Nestlé products remain unaffected and safe for consumption. The authority detailed that the identified batches have been immediately quarantined within Nestlé’s and distributors’ warehouses. A comprehensive process is now underway to ensure the complete removal of these products from all retail channels, including online marketplaces, to safeguard consumer health and safety in alignment with the nation’s stringent regulatory protocols.